BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30945024)

  • 1. Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.
    Alexander C; Prajith NU; Priyanka PV; Nithyakumar A; Arockia Samy N
    J Biol Inorg Chem; 2019 May; 24(3):405-418. PubMed ID: 30945024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
    Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
    J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand.
    Riccardi C; Capasso D; Rozza GM; Platella C; Montesarchio D; Di Gaetano S; Marzo T; Pratesi A; Messori L; Roviello GN; Musumeci D
    J Inorg Biochem; 2020 Feb; 203():110868. PubMed ID: 31837618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bis(triazinyl)pyridine complexes of Pt(II) and Pd(II): studies of the nucleophilic substitution reactions, DNA/HSA interactions, molecular docking and biological activity.
    Jovanović-Stević S; Radisavljević S; Scheurer A; Ćoćić D; Šmit B; Petković M; Živanović MN; Virijević K; Petrović B
    J Biol Inorg Chem; 2021 Aug; 26(5):625-637. PubMed ID: 34268603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic activity and influence on acetylcholinesterase of series dinuclear platinum(II) complexes with aromatic nitrogen-containing heterocyclic bridging ligands: Insights in the mechanisms of action.
    Bondžić AM; Žakula JJ; Korićanac LB; Keta OD; Janjić GV; Đorđević IS; Rajković SU
    Chem Biol Interact; 2022 Jan; 351():109708. PubMed ID: 34666020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
    Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
    Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
    Sun Y; Wei H; Zhang Q; Zhao X
    Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palladium(II) complexes of tridentate bis(benzazole) ligands: Structural, substitution kinetics, DNA interactions and cytotoxicity studies.
    Omondi RO; Bellam R; Ojwach SO; Jaganyi D; Fatokun AA
    J Inorg Biochem; 2020 Sep; 210():111156. PubMed ID: 32645652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.
    Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T
    Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
    Franich AA; Živković MD; Ilić-Tomić T; Đorđević IS; Nikodinović-Runić J; Pavić A; Janjić GV; Rajković S
    J Biol Inorg Chem; 2020 May; 25(3):395-409. PubMed ID: 32162071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cytotoxic activities, DNA- and BSA-binding studies of dinuclear palladium(II) complexes with different pyridine-based bridging ligands.
    Franich AA; Živković MD; Milovanović J; Arsenijević D; Arsenijević A; Milovanović M; Djuran MI; Rajković S
    J Inorg Biochem; 2020 Sep; 210():111158. PubMed ID: 32622215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appended Aromatic Moieties Determine the Cytotoxicity of Neutral Cyclometalated Platinum(II) Complexes Derived from 2-(2-Pyridyl)benzimidazole.
    Vaquero M; Busto N; Fernández-Pampín N; Espino G; García B
    Inorg Chem; 2020 Apr; 59(7):4961-4971. PubMed ID: 32182052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
    Hajipour F; Mahdavinia M; Fereidoonnezhad M
    Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, and in vitro antiproliferative activity of [salophene]platinum(II) complexes.
    Proetto MT; Liu W; Molchanov A; Sheldrick WS; Hagenbach A; Abram U; Gust R
    ChemMedChem; 2014 Jun; 9(6):1176-87. PubMed ID: 24844419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel platinum complexes of imidazolyl-containing bisphosphonates as potential anticancer agents.
    Qiu L; Lv G; Cao Y; Chen L; Yang H; Luo S; Zou M; Lin J
    J Biol Inorg Chem; 2015 Dec; 20(8):1263-75. PubMed ID: 26531104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures and anticancer activity of chlorido platinum(II) saccharinate complexes with mono- and dialkylphenylphosphines.
    Icsel C; Yilmaz VT; Cevatemre B; Aygun M; Ulukaya E
    J Inorg Biochem; 2019 Jun; 195():39-50. PubMed ID: 30889415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New palladium and platinum complexes with bioactive 3,5-diacetyl-1,2,4-triazol bis(4-cyclohexyl thiosemicarbazone) ligand: chemistry, antiproliferative activity and preliminary toxicity studies.
    Matesanz AI; Perles J; Souza P
    Dalton Trans; 2012 Oct; 41(40):12538-47. PubMed ID: 22955178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.